Bryan Co. residents spars with school board over tax exemption
BRYAN COUNTY, Ga. (WSAV) – The Bryan County School Board is at odds with a group of residents about whether to opt into a new tax exemption that could have a significant impact on their wallets.
The people of Georgia voted in favor of the homestead tax exemption, or House Bill 581, last November.
The exemption now applies to any municipalities that opt in. However, the Bryan County School District said they intend to opt out, which would mean increased tax revenue that would go toward county schools.
About a dozen people gathered on the side of Ford Ave Wednesday evening holding signs with slogans like 'save our homes.'
'We started organizing a collective of us. Right now, we're about 300 members where we're trying to inform the community about HB 581 is to save our homes, put out that information to our neighbors and local community and then have our voice heard,' Grant, a Bryan County resident, said.
H.B. 581 is a cap on property taxes that locks in assessed value for homeowners if their local government opts in.
'Even though we already voted in the November election, part of the law allows the seven members of the board of education to opt out of that law,' Grant said.
Bryan County Schools said that they do intend to opt out.
Though, according to a representative for Bryan County, close to 70% of Bryan County voters cast their ballot in favor of the tax exemption.
'The county and the city both are opting in. The school board is the only government entity in Bryan County that is wanting to opt out,' Stephanie Falls, a Bryan County resident, said.
Residents said they're most worried about young families who want to buy their first homes or older people on fixed incomes being priced out.
'Of course we want a well-educated community. We would just like to see a better, more fiscally responsible budget,' Falls said.
The Bryan County Board of Education (BOE) is hosting a public forum tomorrow night at 6:30 p.m. at the Bryan County BOE Central Office about the tax exemption.
News 3 reached out to the board for further comment but have not heard back.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
ST. PAUL, Minn., June 10, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing in India. "The blood cancer burden on India's population is substantial, around 120,000 new cases of lymphoma, leukemia, and multiple myeloma are diagnosed each year. Unfortunately, almost 70,000 Indians will die every year from these afflictions, devastating the lives of their families and communities. To afford access to all Indian patients in need, and to capitalize on the immense commercial potential of our pipeline, we need to think prudently and practically about our manufacturing approach. In the short term, our manufacturing demands are almost 200 drug products per day, and this may increase as CAR-T cell therapies move closer to front line treatment. The only practical way for us to industrialize our production and produce a supply of drug product commensurate with total patient demand is to transition to G-Rex," said Dr. Lakshmikanth Gandikota, Head of R&D, MSAT Intellectual Property, and Translational Research, at Immuneel Therapeutics Limited. "We are extremely impressed by the speed, resourcefulness, creativity, discipline, and entrepreneurialism of the team at Immuneel and are happy to see that India, as a whole, is making significant strides toward CAR-T availability. It gives us a great sense of satisfaction to be in a position to help bring hope to cancer patients in India, one G-Rex at a time," said John Wilson, CEO of Wilson Wolf and co-inventor of G-Rex. As part of Immuneel's G-Rex Grant, they will perform process development, qualification, and validation of a G-Rex based CAR-T cell therapy production approach to dramatically increase the throughput capacity of their state-of-the-art, 12,000 square foot GMP facility. Located in Bengaluru and opened in 2021, Immuneel's Integrated Cell Therapy Development and Manufacturing Facility was the first of its kind in India and is designed to bring breakthrough cell and gene therapies to millions of patients in India. Lastly, Immuneel's G-Rex Grant will support the requisite comparability studies necessary to support a post-CAR-T approval manufacturing change from their difficult to scale low throughput all-in-one manufacturing equipment to a much simpler high throughput G-Rex centric approach. The high popularity of ScaleReady's G-Rex Grant Program led ScaleReady to increase award funds from the original amount of $20M to a total of $30M directed towards saving recipients significant time and money by expediting the path to optimized cell and gene-modified cell therapy manufacturing. Two hundred grants have already been awarded with over 50 new applications in the queue. Each G-Rex Grant recipient can obtain up to $300,000 and gain access to exclusive support from ScaleReady's growing consortium of G-Rex Grant Partners who bring best-in-class tools and technologies as well as unparalleled knowledge and expertise in the areas of cGMP manufacturing, quality and regulatory affairs, CGT business operations, and more. For more information about the G-Rex® Grant Program, please contact info@ About ScaleReadyScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and affordable CGT drug product development and manufacturing. The G-Rex manufacturing platform is currently used by a rapidly growing list of over 800 organizations and is producing drug products for approximately 50% of CGT clinical trials as well as 5 commercially approved CGT drugs. CGT entities relying on the breadth and scope of ScaleReady's expertise can expect to save years of time and millions of dollars on the path to CGT commercialization. For more information about the ScaleReady G-Rex® Grant Program, please contact info@ About Wilson Wolf ManufacturingWilson Wolf ( is dedicated to simplifying cell and gene-modified cell (CGT) therapy research, process development, and manufacturing. This is being accomplished through its scalable G-Rex technology, which is used throughout the world in CGT applications ranging from basic research to commercial drug production. Wilson Wolf's mission is to create hope for cancer patients, one G-Rex® device at a time. About Bio-Techne CorporationBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex® Bioreactors, including right-sized reagent quantities in containers that are tailored to high throughput closed-system manufacturing. For more information on Bio-Techne and its brands, please visit or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube. Contact: David Clair, Vice President, Investor Relations & Corporate About CellReady LLCCellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About Immuneel therapeutics Private LimitedImmuneel Therapeutics Private Limited is a cutting-edge biotechnology company based in Bangalore, India, at the forefront of advancing cell and gene therapies, as well as personalized immunotherapies, for cancer patients in India. As a research-driven and fully integrated organization, Immuneel is dedicated to making next-generation cancer treatments accessible and affordable, with a strong focus on innovation and clinical impact. The company's mission is to democratize advanced therapies by developing and commercializing breakthrough solutions tailored to the needs of Indian patients. As part of its growing portfolio, Immuneel has licensed and commercialized Qartemi® (varnimcabtagene autoleucel), a CD19 CAR-T cell therapy approved by India's Central Drugs Standard Control Organization (CDSCO) for the treatment of adult B-cell non-Hodgkin lymphoma a novel therapy for blood cancer, further demonstrating its commitment to transforming cancer care in India. Immuneel has a robust pipeline of CAR-T therapies for various indications in Oncology and AutoImmune diseases For more information, please visit: View original content to download multimedia: SOURCE Bio-Techne Corporation
Yahoo
9 hours ago
- Yahoo
More questions, calls for accountability after Epic superintendent resigns
OKLAHOMA CITY (KFOR) — Less than a week after layoffs left Epic Charter Schools educators stunned, the district's longtime superintendent has resigned—leading to more questions and renewed calls for week, News 4 reported Epic laid off more than 350 employees, including nearly 100 teachers and all the district's principals—without giving remaining educators a game plan. 'We have not been told any information,' one teacher told News 4. 'How do you have a school without a principal?'Now, the person whose job it would be to come up with that game plan has thrown in the superintendent and CEO Bart Banfield resigned on been with the charter district since 2014, becoming superintendent in led the school through a massive scandal when a grand jury indicted its three founders in 2022, accusing them of embezzling millions in taxpayer dollars from the was also at the helm during a round of teacher layoffs in October, blamed on declining post-COVID Monday, News 4 uncovered Epic payroll records showing, as enrollment went down, Banfield's yearly pay went up—from $276,885 in 2022 to $329,381 by teachers spared in last week's layoffs told News 4 Epic made them sign agreements to cut their base pay by one-third or lose their jobs.'Everything felt like maybe a little bit disingenuous because it felt more like we are a machine than we are a public school system,' one teacher who lost their jobs felt blindsided.'We just had our graduation ceremonies last weekend. There was no word then about anything like this,' a laid-off employee Sen. Carri Hicks (D-Oklahoma City) said she isn't sure something so out-of-the-blue would have been allowed to happen if Epic were a traditional public school district.'It's a charter school,' Hicks said. 'They don't have a publicly elected school board that is really vetting these decisions. Their response, to be accountable to the public is very different than a traditional public school.'Former State Rep. Mark McBride, who chaired the House Education Committee when Epic's founders were indicted in 2022, sees a lot of parallels in the district's new issues.'It's the same—it's the same problem of managing money,' McBride said. 'I'll still always question whether this is a viable charter school for the state, because it seems like there's always something following them around from the beginning.'Hicks sees a potential solution.'When we look at states like North Carolina and other states across the country, they have very different models set up that would help prevent and protect the public from the actions that we're currently seeing from Epic Charter Schools,' Hicks said the power to get there lies solely with lawmakers.'I think it's time to really look at some significant changes that would actually bring a stronger voice to the public and make sure that all charter schools are accountable to the public,' Hicks 4 reached out to the president of the Oklahoma Statewide Charter School Board, which oversees Epic, to ask if he or the board had any thoughts on Banfield's 4 did not hear back. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
10 hours ago
- Yahoo
PA House passes bill requiring American-made steel in tax-payer funded projects
HARRISBURG, Pa. (WHTM) — The Pennsylvania House of Representatives passed a bill Monday requiring American-made steel for all tax-payer funded projects. State law already requires government projects to use American-made steel. However, H.B. 1018 would extend this requirement to private entities receiving public funds or tax incentives. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now 'This is one way to bring back good-paying, family-sustaining jobs – by leveling the playing field for hardworking people and industries that were economically steamrolled by unfair competition,' said Rep. Frank Burns (D-Cambria), who sponsored the bill. The bill, which is a part of Burns' larger 'American Made Jobs Plan,' passed the House 200-2. It will now move to the Senate for concurrence. Mexican aluminum, steel exporters say sales in US down 63% due to tariffs The bill comes as tariffs have driven down the demand for foreign-made steel. In February, President Donald Trump ordered a 25% tariff on Mexican and Canadian steel and aluminum imports. Exporters of Mexican steel and aluminum said that has led to a 63% drop in sales to the United States. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
